SFU
GILD icon

Stonehage Fleming (UK)’s Gilead Sciences GILD Stock Holding History

Stonehage Fleming (UK)’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-8,310
Closed -$973K – 198
2015
Q1 		$973K Buy
+8,310
New +$844K 0.45% 74
2014
Q1 		– Sell
-47,696
Closed -$3.58M – 312
2013
Q4 		$3.58M Buy
+47,696
New +$3.32M 1.45% 15

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stonehage Fleming (UK)'s GILD Position: Q2 2015 in Review

Stonehage Fleming (UK) sold out of Gilead Sciences (GILD) in Q2 2015, closing a stake of 8,310 shares — an estimated $973K sold.

Stonehage Fleming (UK) first reported a position in GILD in Q4 2013 and held it in 2 quarters. The position peaked at $3.58M in Q4 2013. 1,560 funds tracked by Wall St. Rank hold GILD as of Q2 2015.

  • Stonehage Fleming (UK) reported no remaining Gilead Sciences position as of Q2 2015 after selling out during the quarter.
  • Stonehage Fleming (UK) sold 8,310 Gilead Sciences shares in Q2 2015, an estimated $973K.
  • Stonehage Fleming (UK) first reported a position in Gilead Sciences in Q4 2013 and held it in 2 quarters.
  • Stonehage Fleming (UK)'s Gilead Sciences position peaked at $3.58M in Q4 2013.
  • 1,560 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2015.

Based on Stonehage Fleming (UK)'s 13F filing for Q2 2015, filed 11 Oct 2019.